Artificial Intelligence to Measure Adherence to Oral Medication
Purpose
The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.
Condition
- First Episode Psychosis
Eligibility
- Eligible Ages
- Between 15 Years and 40 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Enrolled in a CSC program - Prescribed an oral antipsychotic
Exclusion Criteria
- none
Study Design
- Phase
- Phase 4
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Other
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Smartphone App |
artificial intelligence (AI) smartphone app to provide support for medication adherence |
|
|
Active Comparator Usual Care |
Usual care provided at CSC clinic |
|
Recruiting Locations
Hialeah, Florida 33012
Grand Rapids, Michigan 49503
Jacob Gonzalez
Kalamazoo, Michigan 49007
Dana Schrader
Oklahoma City, Oklahoma 73105
Tulsa, Oklahoma 74315
More Details
- Status
- Recruiting
- Sponsor
- Northwell Health
Detailed Description
The challenge of oral medication adherence in first-episode psychosis (as in any potentially chronic illness) is enormous, and numerous studies have linked non-adherence to increased rates of relapse/ hospitalization. Determining whether a patient is adhering to medication is a challenge. Pill counts, pharmacy records, technology-assisted monitoring, biological assays, and a range of self-report and interviewer-rated scales have been employed. In other areas of medicine such as antiretroviral treatment Direct Observation of Treatment (DOT) has been employed with excellent success both in monitoring and demonstrated improvement of important clinical outcomes. DOT is clearly not feasible in community settings. An artificial Intelligence (AI) platform that can be downloaded as an application onto a smart phone app represents a novel approach to offering DOT to support participant oral medication adherence and thereby improve outcomes. Aims of the project are: 1) to document acceptability to patients of the AI smartphone app based upon participation in the study and 2) to compare rates of hospitalization and emergency room visits between participants who receive the AI smartphone app with participants who receive standard care.